News
News

The latest updates from AFAR.

Steve Austad’s lastest Next Avenue column on dietary timing, healthy aging, and research by AFAR experts Valter Longo and Satchin Panda

Aug 30
2018

Steve Austad’s lastest Next Avenue column on dietary timing, healthy aging, and research by AFAR experts Valter Longo and Satchin Panda

On August 31, 2018, Next Avenue published the latest column by AFAR Scientific Director Steven Austad, Ph.D. “It’s Not Just What You Eat -- It’s When You Eat” explores how mice studies have shown the impact of fasting on healthspan and resilience. Dr. Austad spotlights the research on fast-mimicking diets, caloric restriction, and the body’s Circadian rhythm, advanced by two AFAR experts: • 2013 Vincent Cristofalo Rising Star Award in Aging Research recipient Valter D. Longo, Ph.D. • 2014 Julie Martin Mid-Career Award in Aging Research recipient Satchidananda Panda, Ph.D. “Led…


View MoreREAD MORE


Grantee in the News: Rozalyn Anderson in Business Insider on caloric restriction, metabolism, and aging

Aug 30
2018

Grantee in the News: Rozalyn Anderson in Business Insider on caloric restriction, metabolism, and aging

On August 23, 2018, Business Insider highlighted the research of AFAR expert Rozalyn Anderson, Ph.D. Dr. Anderson is a 2016 Glenn/AFAR Breakthroughs in Gerontology (BIG) Award winner. Read the full article, “A scientist who studies aging reveals how restricting calories might offer protection against age-related diseases,” here.


View MoreREAD MORE


Grantees in the News: Research by Elly Nedivi and Jason Shepherd in The Journal of Neuroscience on antidepressants, brain plasticity, and cognitive aging

Aug 20
2018

Grantees in the News: Research by Elly Nedivi and Jason Shepherd in The Journal of Neuroscience on antidepressants, brain plasticity, and cognitive aging

On August 14, 2018, The Journal of Neuroscience published research co-authored by AFAR experts Elly Nedivi, Ph.D. and Jason Shepherd, Ph.D. Dr. Nedivi is a 2007 Julie Martin Mid-Career Awards in Aging Research grantee. Dr. Shepherd is a 2003 Glenn/AFAR Scholarship for Research in the Biology of Aging grantee. Read the published research, “Interneuron simplification and loss of structural plasticity as markers of aging-related functional decline,” by subscription-only here. Read a related article in Health Medicine Network here.


View MoreREAD MORE


Grantee in the News: Reisa Sperling in AlzForum on the A4 study and the preclinical stages of Alzheimer’s Disease

Aug 20
2018

Grantee in the News: Reisa Sperling in AlzForum on the A4 study and the preclinical stages of Alzheimer’s Disease

On August 17, 2018, AlzForum highlighted research by AFAR expert Reisa Sperling, M.D. M.M.Sc. Dr. Sperling is a 2003 Paul B. Beeson Emerging Leaders in Aging Scholar recipient. Read the full article, “Memory Slips as Soon as Amyloid Appears, Two Decades Before Dementia,” here.


View MoreREAD MORE


Board member in the News: Deputy Scientific Director Nir Barzilai and the TAME trial  in Vox and Netflix “Explained

Aug 17
2018

Board member in the News: Deputy Scientific Director Nir Barzilai and the TAME trial in Vox and Netflix “Explained"

On August 15, 2018, Netflix and Vox's “Explained” series premiered a new episode focusing on aging research and longevity; AFAR expert Nir Barzilai, MD lends insight on the promise of aging research and the Targeting Aging with Metformin (TAME) Trial, which AFAR helps manage. Dr. Barzilai is AFAR’s Deputy Scientific Director, a multiple AFAR grantee, and Director of the Nathan Shock Center of Excellence in the Basic Biology of Aging at Albert Einstein College of Medicine, for which AFAR serves as the Coordinating Center. Find the Explained episode--“Can We Live Forever?—on…


View MoreREAD MORE


Grantees in the News: Rozalyn Anderson and Richard Miller on naked mole rats and aging in Business Insider

Aug 17
2018

Grantees in the News: Rozalyn Anderson and Richard Miller on naked mole rats and aging in Business Insider

On August 15, 2018, Business Insider featured insights from AFAR experts Rozlyn Anderson, PhD and Richard Miller, MD, PhD in an article exploring what naked mole rats reveal about aging and longevity. Dr. Anderson is a 2016 Glenn/AFAR Breakthroughs in Gerontology (BIG) Award winner. Dr. Miller is a 1985 AFAR Research Grant recipient Richard Miller, MD, PhD and recent AFAR Scientific Committee member. Read the Business Insider article—"Animals that defy the rules of aging--like naked mole rats--could help scientists unravel the secrets to longevity”—here.        


View MoreREAD MORE


Awardee in the News: Valter Longo’s research on intermittent fasting in Business Insider

Aug 16
2018

Awardee in the News: Valter Longo’s research on intermittent fasting in Business Insider

On August 15, 2018, Business Insider highlighted research on the benefits of intermittent fasting by AFAR expert Valter Longo, PhD. Dr. Longo is 2013 Vincent Cristofalo Rising Star Award in Aging Research recipient. Read the article—"The amazing ways intermittent fasting affects your body and brain”—here.


View MoreREAD MORE


Board member in the News: David Sinclair on Frailty and NAD boosters in Science Trends

Aug 15
2018

Board member in the News: David Sinclair on Frailty and NAD boosters in Science Trends

On August 14, 2018, Science Trends published an article co-authored by AFAR expert David Sinclair, PhD. Dr. Sinclair is a 2000 AFAR Research Grant recipient and current AFAR Board Member. Read the article--“Why We Get Frail And How To Reverse It”--here.    


View MoreREAD MORE


Grantee in the News: Lin Guo in Molecular Cell on cancer drugs that may fight brain diseases

Aug 13
2018

Grantee in the News: Lin Guo in Molecular Cell on cancer drugs that may fight brain diseases

On August 9, 2018, Molecular Cell published research co-authored by AFAR grantee Lin Guo, PhD. Dr. Guo is a 2014 Ellison/AFAR Postdoctoral Fellows in Aging Research Program recipient. Read the published research article, “Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule,” here, as well as a related press release here.  


View MoreREAD MORE


Grantee in the News: Jason Karlawish on Gates Foundation and Alzheimer’s in Forbes

Aug 09
2018

Grantee in the News: Jason Karlawish on Gates Foundation and Alzheimer’s in Forbes

On August 4, 2018, Forbes published the latest column by AFAR expert Jason Karlawish, MD. The piece explores the potential impact that the Gates Foundation could have on Alzheimer’s research. Dr. Karlawish is a 2007 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar. Read the full article, “How Bill Gates Could Transform Alzheimer's Disease” here.  


View MoreREAD MORE


Grantee in the News: Malaz Boustani on iterative design, data collection, and aging research in HealthITAnalytics

Aug 08
2018

Grantee in the News: Malaz Boustani on iterative design, data collection, and aging research in HealthITAnalytics

On August 7, 2018, HealthITAnalytics featured insights from two-time AFAR grantee Malaz Boustani, MD, MPH. Dr. Boustani is a 2005 Paul B. Beeson Career Development Awards in Aging Research winner and 2000 Center of Excellence fellow. Read the full article, “Using Big Data Analytics for Patient Safety, Hospital Acquired Conditions,” here.


View MoreREAD MORE


Research driven by AFAR experts spotlighted in Forbes

Aug 06
2018

Research driven by AFAR experts spotlighted in Forbes

On August 2, 2018, Forbes highlighted research driven by several AFAR experts. Former Vincent Cristofalo Rising Star Award in Aging Research winner Valter D. Longo, PhD and his research on caloric restriction and intermittent fasting are spotlighted. The article also highlights the Targeting Aging with Metformin (TAME) Trial led by AFAR Deputy Scientific Director Nir Barzilai, MD, as well as advances in senolytics led by Unity Biotechnology, which was co-founded by AFAR board member Nathaniel E.  David, PhD and AFAR grantee Judith Campisi, PhD. Read the full article, “The Future of Aging, Bringing Hollywood to the Hospital,” here.


View MoreREAD MORE


Grantees in the News: Rozalyn Anderson and Dudley Lamming research in Aging Cell on  AT-1 protein, accelerated aging, and Progeria-like phenotype

Aug 03
2018

Grantees in the News: Rozalyn Anderson and Dudley Lamming research in Aging Cell on AT-1 protein, accelerated aging, and Progeria-like phenotype

On July 27, 2018, Aging Cell published research co-authored by AFAR experts Rozalyn Anderson, Ph.D. and Dudley Lamming, Ph.D. Dr. Rozalyn Anderson is a 2016 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award winner. Dr. Dudley Lamming is a 2015 Glenn Foundation for Medical Research and AFAR Research Grant for Junior Faculty recipient and 2017 Nathan Shock Center Pilot grantee. Read the published research, “Increased transport of acetyl‐CoA into the endoplasmic reticulum causes a progeria‐like phenotype,” here and a related press release here.


View MoreREAD MORE


Grantee in the News: Reisa Sperling in Scientific American and STAT News on study testing a new drug to remove amyloid plaques

Aug 01
2018

Grantee in the News: Reisa Sperling in Scientific American and STAT News on study testing a new drug to remove amyloid plaques

On July 30, 2018, Scientific American and STAT News highlighted the insights of AFAR expert Reisa Sperling, M.D. M.M.Sc. Dr. Sperling is a 2003 Paul B. Beeson Emerging Leaders in Aging Scholar recipient. Read the full article, “Alzheimer’s Study Sparks New Round of Debate over the Amyloid Hypothesis,” here.


View MoreREAD MORE


Watch a video of Nir Barzilai at Metabesity 2017 on the Targeting Aging with Metformin (TAME) Trial

Aug 01
2018

Watch a video of Nir Barzilai at Metabesity 2017 on the Targeting Aging with Metformin (TAME) Trial

AFAR is pleased to share this video featuring Deputy Scientific Director and multiple-grantee Nir Barzilai, M.D. In the video, Dr. Barzilai discusses the Targeting Aging with Metformin (TAME) study, his research on centenarians and longevity, and the goal to extend healthspan. The presentation is framed around the topic of Metabesity, which looks at “the armada of metabolic diseases that include diabetes, obesity, metabolic syndrome, cardiovascular disease, neurodegenerative disorders and accelerated aging. These diseases share both metabolic and inflammatory roots.” Watch the video, “Metabesity 2017: Qualifying Clinical Candidates for Anti Aging Interventions,” here.


View MoreREAD MORE




BACK TO TOPBACK TO TOP